Rapid-Sequence Intubation: A Review of the Process and Considerations When Choosing Medications

Annals of Pharmacotherapy

Volumn 48, Issue 1, 2014, Pages 62-76

  Stollings, Joanna L ^a   Diedrich, Daniel A ^b   Oyen, Lance J ^b   Brown, Daniel R ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

etomidate; induction agents; ketamine; neuromuscular blockers; premedications; propofol; rapid sequence intubation

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM BESILATE; ATROPINE; ETOMIDATE; FENTANYL; KETAMINE; LIDOCAINE; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; PHENYLEPHRINE; PROPOFOL; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ANESTHESIA INDUCTION; CRITICALLY ILL PATIENT; DRUG CHOICE; ENDOTRACHEAL INTUBATION; HUMAN; MEDLINE; PREMEDICATION; PRIORITY JOURNAL; RAPID SEQUENCE INTUBATION; REVIEW;

ETOMIDATE; INDUCTION AGENTS; KETAMINE; NEUROMUSCULAR BLOCKERS; PREMEDICATIONS; PROPOFOL; RAPID-SEQUENCE INTUBATION;

ANTI-ANXIETY AGENTS; HUMANS; HYPNOTICS AND SEDATIVES; INTUBATION, INTRATRACHEAL; NEUROMUSCULAR BLOCKING AGENTS;

EID: 84892854482     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013510488     Document Type: Review

References (90)

1. Mace SA.Challenges and advances in intubation: rapid sequence intubation.Emerg Med Clin N Am. 2008;26:1043-1068.
2. Caro D,Tyler KManual of Emergency Airway Management. 4th ed.Philadelphia, PA: Lippincott Williams &Wilkins; 2012:242-251.Walls RMMurphy MF, ed. Philadelphia, PA: Lippincott Williams &Wilkins; 242-251.
3. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters.Anesthesiology. 2011;3:495-511.
4. Sellick BA.Cricoid pressure to control regurgitation of stomach contents during induction of anesthesia.Lancet. 1961;2:404-406.
5. Vanner RG,Pryle BJ,O'Dwyer JP, et al.Upper oesophageal sphincter pressure during inhalational anaesthesia.Anaesthesia. 1992;47:950-954.
6. VissersRJ. Tracheal intubation and mechanical ventilation. In: TintinalliJEStapczynskiJSClineDMMaOJCydulkaRKMecklerGD eds. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. 7th ed.New York, NY: McGraw-Hill; 2011:chap 30. http://www.accessmedicine.com/content.aspx?aID=6369632. Accessed August 12, 2013.
7. Caro D,Bush SManual of Emergency Airway Management. 4th ed.Philadelphia, PA: Lippincott Williams &Wilkins; 2012:234-239.Walls RMMurphy MF, ed. Philadelphia, PA: Lippincott Williams &Wilkins; 234-239.
8. Frakes MA.Rapid sequence induction medications: an update.J Emerg Nurs. 2003;29:533-540.
9. Lake Forest, IL: Hospira Inc; 2010:.
10. Hampron JP.Rapid-sequence intubation and the role of the emergency department pharmacist.Am J Health Syst Pharm. 2011;68:1320-1330.
11. KnowlesJRainsA. Compromised airway. In: HumphriesRLStoneC eds. Current Diagnosis and Treatment Emergency Medicine. 7th ed.New York, NY: McGraw-Hill; 2011:chap 10. http://www.accessmedicine.com/content.aspx?aID=55747312. Accessed August 12, 2013.
12. Deerfield, IL: Baxter Healthcare Corporation; 2010:.
13. Mort TC.Complications of emergency tracheal intubation: hemodynamic alterations. Part I.J Intensive Care Med. 2007;22:157-165.
14. Lake Forest, IL: Hospira, Inc; 2011:.
15. Vaillaincourt C,Kapur AK.Opposition to the use of lidocaine in rapid sequence intubation.Ann Emerg Med. 2007;49:86-87.
16. Asfar SN,Abdulla WY.The effect of various administration routes of lidocaine on hemodynamics and ECG rhythm during endotracheal intubation.Acta Anaesthesiol Belg. 1990;41:17-24.
17. Samaha T,Ravussin P,Clauquin C, et al.Prevention of increase of blood pressure and intracranial pressure during endotracheal intubation in neurosurgery: esmolol versus lidocaine.Ann Fr Anesth Reanim. 1996;15:36-40.
18. Bedford RF,Winn HR,Tyson G, et alIntracranial Pressure IV. Shulman KMamorou IMiller JD, ed. Berlin, Germany: Springer-Verlag; 1980:595-598.
19. Hamill JF,Bedford RF,Weaver DC, et al.Lidocaine before endotracheal intubation: intravenous or laryngotracheal.Anesthesiology. 1981;55:578-581.
20. Lake Forest, IL: Hospira, Inc; 2006:.
21. Nemeth J,Maghragby N,Kazim S.Emergency airway management: the difficult airway.Emerg Med Clin N Am. 2012;30:401-420.
22. Diaz-Guzman E,Mireles-Cabodevila E,Heresi GA, et al.A comparison of methohexital versus etomidate for endotracheal intubation of critically ill patients.Am J Crit Care. 2010;19:48-54.
23. Sivilotti ML,Ducharme J.Randomized, double-blind study on sedatives and hemodynamics during rapid-sequence intubation in the emergency department: The SHRED Study.Ann Emerg Med. 1998;31:313-324.
24. Herregods L,Verbeke J,Rolly G,Colardyn F.Effect of propofol on elevated intracranial pressure: preliminary results.Anaesthesia. 1988;43 (suppl): 107-109.
25. Hildreth MN,Mejia VA,Maxwell RA, et al.Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study.J Trauma. 2009;65:573-579.
26. Mohammed Z,Afessa B,Fienkelman JD.The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate.Crit Care. 2006;10:R105.
27. Watt I,Ledingham IM.Mortality amongst multiple trauma patients admitted to an intensive therapy unit.Anaesthesia. 1984;39:973-981.
28. Absalom A,Pledger D,Kong A.Adrenocortical function in critically ill patients 24 h after a single dose of etomidate.Anaesthesia. 1999;54:861-867.
29. Vinclair M,Broux C,Faure P, et al.Duration of adrenal inhibition following a single dose of etomidate in critically ill patients.Intensive Care Med. 2008;34:714-719.
30. Albert SG,Ariyan S,Rather A.The effect of etomidate on adrenal function in critical illness: a systematic review.Intensive Care Med. 2011;37:901-910.
31. Schenarts CL.Adrenocortical dysfunction following etomidate induction in emergency department patients.Acad Emerg Med. 2001;8:1-7.
32. Cotton BA,Guillamondegui OD,Fleming SB, et al.Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients.Arch Surg. 2008;143:62-67.
33. Cuthbertson B,Sprung DL,Annane D, et al.The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock.Intensive Care Med. 2009;35:1868-1876.
34. Kolenda H,Gremmelt A,Rading S, et al.Ketamine for analgosedative therapy in intensive care treatment of head injured patient.Acta Neurochir (Wien). 1996;138:1193-1199.
35. Albanese K,Arnaud S,Rey M, et al.Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation.Anesthesiology. 1997;87:1328-1334.
36. Bourgoin A,Albanese J,Wereszczynski N, et al.Safety of sedation with ketamine in severe head injury patients comparison with sufentanil.Crit Care Med. 2003;31:711-717.
37. Langsjo JW,Kaisti KK,Aalto S, et al.Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans.Anesthesiology. 2003;99:614-623.
38. Bourgoin A,Albanese J,Leone M, et al.Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients.Crit Care Med. 2005;33:1109-1113.
39. Jabre P,Combes X,Lapostolle F, et al.Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial.Lancet. 2009;374:293-300.
40. Smischney NJ,Beach ML,Lortus RW, et al.Ketamine/propofol admixture (ketofol) is associated with improved hemodynamics as an induction agent: a randomized, controlled trial.J Trauma Acute Care Surg. 2012;73:94-101.
41. Sagarin MJ,Barton ED,Sakles JC, et al.Underdosing of midazolam in emergency endotracheal intubation.Acad Emerg Med. 2003;10:329-338.
42. Biane A,Ract C,Leblanc PE, et al.The limits of succinylcholine for critically ill patients.Anesth Analg. 2012;115:873-879.
43. Perry JJ,Lee JS,Sillberg VAH,Wells GA.Rocuronium versus succinylcholine for rapid sequence induction intubation.Cochrane Database Syst Rev. 2008; (2).
44. Marsch SC,Steiner L,Bucher E, et al.Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial.Crit Care. 2011;15:R1999.
45. Davison KL,Holland MS.A comparison study of vecuronium bromide and atracurium besylate for rapid sequence induction.AANA J. 1989;57:37-40.
46. Magorian T,Flannery KB,Miller RD.Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients.Anesthesiology. 1993;79:913-918.
47. Smith CE,Kovach B,Polk JD, et al.Prehospital tracheal intubating conditions during rapid sequence intubation: rocuronium versus vecuronium.Air Med J. 2002;21:26-32.
48. Russo H,Bressolle F.Pharmacodynamics and pharmacokinetics of thiopental.Clin Pharmacokinet. 1998;35:95-134.
49. Reich DL,Hossain S,Krol M, et al.Predictors of hypotension after induction of general anesthesia.Anesth Analg. 2005;101:622-628.
50. Patel PM,Patel HH,Roth DMGoodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed.New York, NY: McGraw-Hill; 2011:chap 19.Brunton LLChabner BAKnollmann BC, ed. New York, NY: McGraw-Hill; 2011:.
51. McKeage K,Perry CM.Propofol: a review of its use in intensive care sedation of adults.CNS Drugs. 2003;17:235-272.
52. Barr J.Propofol: a new drug for sedation in the intensive care unit.Int Anesthesiol Clin. 1995;33:131-154.
53. Wilbur K,Zed PJ.Is propofol an optimal agent for procedural sedation and rapid sequence intubation in the emergency department.CJEM. 2001;3:302-310.
54. Diedrich DA,Brown DR.Analytic reviews: propofol infusion syndrome in the ICU.J Intensive Care Med. 2011;26:59-72.
55. Dewachter P,Mouton-Faivre C,Castells MC, et al.Anesthesia in the patient with multiple drug allergies: are all drug allergies the same?.Curr Opin Anesthesiol. 2011;24:320-325.
56. Bergen JM,Smith DC.A review of etomidate for rapid sequence intubation in the emergency department.J Emerg Med. 1997;15:221-230.
57. Schaumburg, IL: Sagent Pharmaceuticals, Inc; 2012:.
58. Drake WM,Perry LA,Hinds CJ, et al.Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in patients with Cushing's syndrome and peritonitis.J Clin Endocrinol Metab. 1998;83:3542-3544.
59. Laskowki K,Stirling A,McKay WP, et al.A systemic review of intravenous ketamine for postoperative analgesia.Can J Anaesth. 2011;58:911-923.
60. Sih K,Campbell SG,Tallon JM, et al.Ketamine in adult emergency medicine: controversies and recent advances.Ann Pharmacother. 2011;45:1525-1534.
61. Shapiro HM,Wyte SR,Harris AB, et al.Ketamine anesthesia in patients with the intracranial pathology.Br J Anaesth. 1972;14:1200-1204.
62. Takeshita H,Okuda Y,Sari A.The effects of ketamine on cerebral circulation and metabolism in man.Anesthesiology. 1972;36:69-75.
63. Bovil JG.Intravenous anesthesia for the patient with left ventricular dysfunction.Semin Cardiothorac Vasc Anesth. 2006;10:43-48.
64. Sener S,Eken C,Shultz CH, et al.Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial.Ann Emerg Med. 2011;57:109.e2-114.e2.
65. Wathen JE,Roback MG,Mackenzie T, et al.Does midazolam alter the clinical effects of intravenous ketamine sedation in children? A double-blind randomized, controlled, emergency department trial.Ann Emerg Med. 2000;36:579-588.
66. Sherwin TS,Green SM,Khan A, et al.Does adjunctive midazolam reduce recovery agitation after ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial.Ann Emerg Med. 2000;35:229-238.
67. Deerfield, IL: Baxter Healthcare Corporation; 2010:.
68. Wilcox SR,Bickner EA,Elmer J, et al.Neuromuscular blocking agent administration for emergent tracheal intubation is associated with decreased prevalence of procedure-related complications.Crit Care Med. 2012;40:1808-1813.
69. Li J,Murphy-Lavoie H,Bugas C, et al.Complications of emergency intubation with and without paralysis.Am J Emerg Med. 1999;17:141-143.
70. Bozeman WP,Kleiner DM,Huggett V.A comparison of rapid-sequence intubation and etomidate-only intubation in the prehospital air medical setting.Prehosp Emerg Care. 2006;10:8-13.
71. Ma OJ,Atchley RB,Hatley T, et al.Intubation success rates improve for an air medical program after implementing the use of neuromuscular blocking agents.Am J Emerg Med. 1998;16:125-127.
72. Vijayakumar E,Bosscher H,Renzi FP, et al.The use of neuromuscular blocking agents in the emergency department to facilitate tracheal intubation in the trauma patient: help or hindrance?.J Crit Care. 1998;13:1-6.
73. Murray MJ,Cowen J,DeBlock H, et al.Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.Crit Care Med. 2002; (1): 142-156.
74. Caro D,Laurin EManual of Emergency Airway Management. 4th ed.Philadelphia, PA: Lippincott Williams & Wilkins; 2012:255-265.Walls RMMurphy MF, ed. Philadelphia, PA: Lippincott Williams & Wilkins; 255-265.
75. McManus MC.Neuromuscular blockers in surgery and intensive care, part 1.Am J Health Syst Pharm. 2001;58:2287-2299.
76. McManus MC.Neuromuscular blockers in surgery and intensive care, part 2.Am J Health Syst Pharm. 2001;58:2381-2395.
77. Lake Forest, IL: Hospira Pharmaceuticals, Inc; 2010:.
78. Sanders DB.Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms and update on therapeutics.Ann Neurol. 1995;37:S63-S73.
79. Wappler F.Malignant hyperthermia.Eur J Anesthesiol. 2001;18:632-652.
80. Thapa S,Brull SJ.Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited.Anesth Analg. 2009;91:237-241.
81. Gronert GA.Cardiac arrest after succinylcholine: mortality greater with rhabdomyolysis than receptor upregulation.Anesthesiology. 2001;94:523-529.
82. Cunningham AJ,Barr P.Intraocular pressure-physiology and implications for anesthetic management.Can Anaesth Soc J. 1986;33:195-208.
83. Vachon CA,Warner DO,Bacon DR.Succinylcholine and the open globe: tracing the teaching.Anesthesiology. 2003;99:220-223.
84. Clancy M,Halford S,Walls R, et al.In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review.Emerg Med J. 2001;18:373-375.
85. FDA rejects Schering-Plough's anaesthetic drug sugammadex NDA. Medical News Today. http://www.medicalnewstoday.com/releases/117156.php. Accessed January 3, 2012.
86. Gijsenbergh F,Ramael S,Houwing N,van Iersel T.First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide.Anesthesiology. 2005;103:695-703.
87. FarrarJTacting chair. Sugammadex NDA 22-225. Meeting of the Anesthetic and Life Support Drugs FDA Advisory Committee;March11, 2008; Silver Spring, MD. http://www.fda.gov/ohrms/dockets/ac/08/agenda/2008-4346a-FINAL.pdf. Assessed October 4, 2012.
88. Naguib M.Sugammadex: another milestone in clinical neuromuscular pharmacology.Anesth Analg. 2007;104:575-581.
89. Schaumburg, IL: APP Pharmaceuticals, Inc; 2008:.
90. American Society of Health System Pharmacists. Drug shortages resource center. http://www.ashp.org/shortage. Accessed April 22, 2012.